Results 61 to 70 of about 5,029 (162)
Thymic origin of abnormal lymphoid cells in Sézary syndrome [PDF]
, 1975 J. C. Ding +3 more
openalex +1 more source
Advances in Immunotherapy for the Treatment of Cutaneous T-Cell Lymphoma
Cancer Management and Research, 2023 Ari Pelcovits,1,2 Thomas A Ollila,1,2 Adam J Olszewski1,2 1Department of Medicine, Alpert Medical School of Brown University, Providence, RI, USA; 2Division of Hematology-Oncology, Rhode Island Hospital, Providence, RI, USACorrespondence: Adam J ...
Pelcovits A, Ollila TA, Olszewski AJ
doaj
Massive IgE-hyperimmunoglobulinemia and storage histiocytosis in Sézary syndrome: A postmortem study [PDF]
, 1984 Haruhiko Miyayama +5 more
openalex +1 more source
EClinicalMedicineSummary: Background: Sézary syndrome is an extremely rare and fatal cutaneous T-cell lymphoma (CTCL). Mogamulizumab, an anti-CCR4 monoclonal antibody, has recently been associated with increased progression-free survival in a randomized clinical trial ...
Alizée Bozonnat +47 more
doaj
OncoImmunology, 2018 CTCL follows different courses depending on the clinical stage at the time of diagnosis. Patients with early stage Mycosis Fungoides (MF) variant of CTCL may experience an indolent course over decades, whereas patients with advanced MF and Sézary ...
Philippe Lefrançois +13 more
doaj +1 more source
Fine-Needle Aspiration Biopsy in the Evaluation of Lymphadenopathy Associated With Cutaneous T-Cell Lymphoma (Mycosis Fungoides/Sézary Syndrome) [PDF]
, 2000 Lorenzo M. Galindo +6 more
openalex +1 more source
Large Cell Transformation of Sézary Syndrome [PDF]
, 2000 Chi‐Chiu So +3 more
openalex +1 more source
Single-cell heterogeneity in Sézary syndrome
Blood Advances, 2018 : Sézary syndrome (SS) is an aggressive leukemic variant of cutaneous T-cell lymphoma (CTCL) with a median life expectancy of less than 4 years. Although initial treatment responses are often good, the vast majority of patients with SS fail to respond to
Terkild Brink Buus +19 more
doaj